Your browser doesn't support javascript.
loading
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer.
Chic, Nuria; Luen, Stephen J; Nuciforo, Paolo; Salgado, Roberto; Fumagalli, Debora; Hilbers, Florentine; Wang, Yingbo; de Azambuja, Evandro; Láng, István; Di Cosimo, Serena; Saura, Cristina; Huober, Jens; Prat, Aleix; Loi, Sherene.
Afiliação
  • Chic N; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Luen SJ; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Nuciforo P; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Salgado R; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Fumagalli D; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hilbers F; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Wang Y; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
  • de Azambuja E; Breast International Group, Brussels, Belgium.
  • Láng I; Breast International Group, Brussels, Belgium.
  • Di Cosimo S; Novartis Pharma AG, Basel, Switzerland.
  • Saura C; Universite Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Huober J; Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.
  • Prat A; Istenhegyi Géndiagnosztika Private Health Center Oncology Clinic, Budapest, Hungary.
  • Loi S; SOLTI Breast Cancer Research Group, Barcelona, Spain.
J Natl Cancer Inst ; 114(3): 467-470, 2022 03 08.
Article em En | MEDLINE | ID: mdl-33787900

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2022 Tipo de documento: Article